Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Center for Drug Evaluation and Research Approval Letter, application number: 21-897
The refinement of genetic predictors of multiple sclerosis.
Substance Name: Phenytoin
Are there Epstein-Barr virus seronegative patients with multiple sclerosis?
The genetics of multiple sclerosis: an up-to-date review.
Interferon Beta Use and Disability Prevention in Relapsing-Remitting Multiple Sclerosis.
Dalfampridine Improves Sensorimotor Function in Rats With Chronic Deficits After Middle Cerebral Artery Occlusion.
Differences in Diffusion Tensor Imaging-Derived Metrics in the Corpus Callosum of Patients With Multiple Sclerosis Without and With Gadolinium-Enhancing Cerebral Lesions.
Evaluating medically at-risk drivers: a survey of assessment practices in Canada.
Multiparametric flow cytometric analysis of whole blood reveals changes in minor lymphocyte subpopulations of multiple sclerosis patients.
Quantitative Evaluation of BAFF, HMGB1, TLR 4 AND TLR 7 Expression in Patients with Relapsing Remitting Multiple Sclerosis.
T-cell vaccination in Crohn's disease: principles and presentation of the first two cases.
The translational biology of remyelination: Past, present, and future.
Expansion of oligodendrocyte progenitor cells following SIRT1 inactivation in the adult brain.
Modeling the heterogeneity of multiple sclerosis in animals.
Activation of Invariant NKT Cells in Early Phase of Experimental Autoimmune Encephalomyelitis Results in Differentiation of Ly6Chi Inflammatory Monocyte to M2 Macrophages and Improved Outcome.
Daily hassles reported by Dutch multiple sclerosis patients.
Impact of Depression, Fatigue and Disability on Quality of Life in Chinese Patients with Multiple Sclerosis.
Alteration of CD1 expression in multiple sclerosis.
Absence of mannose-binding lectin in a female with relapsing-remitting multiple sclerosis.
Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis.
Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection.
A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With Secondary Progressive Multiple Sclerosis (ASCEND in SPMS)
Obstructive sleep apnea and fatigue in patients with multiple sclerosis.
Naltrexone prescribing information

Pages